{"symbol":"ABBV","fiscalQuarter":"Q4-2020","reportDate":"2021-02-03","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2020","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 3.36%","keyNumbers":[{"metric":"EPS","actual":"$2.92","expected":"N/A","surprise":"+2.35%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"AbbVie reported an EPS of $2.92, which exceeded expectations, resulting in a positive stock reaction of 3.36%. However, there was no revenue data provided, and no guidance was issued. The market's response indicates investor confidence in AbbVie's earnings performance despite the lack of additional information.","metaDescription":"AbbVie Inc. (ABBV) Q4 2020 earnings: EPS beat by 2.35%. Stock up 3.36%. Full breakdown."}}